Literature DB >> 12208990

Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus.

Yuko Goto1, Yoshiaki Nishimura, Kenji Baba, Takuya Mizuno, Yasuyuki Endo, Kenichi Masuda, Koichi Ohno, Hajime Tsujimoto.   

Abstract

We measured the quantity of plasma feline immunodeficiency virus (FIV) RNA using a real-time sequence detecting system. Plasma viral RNA load was shown to correlate with the clinical stage, survival time, and disease progression in naturally FIV-infected cats. The present study indicates that the plasma viral RNA load can be used as a clinical marker representing the impairment of the immune system and predicting the clinical outcome in FIV-infected cats.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12208990      PMCID： PMC136479          DOI： 10.1128/jvi.76.19.10079-10083.2002

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  24 in total

1.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Authors:  R A Olmsted; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Clinical staging of feline immunodeficiency virus infection.

Authors:  T Ishida; I Tomoda
Journal:  Nihon Juigaku Zasshi       Date:  1990-06

3.  HIV results in the frame. CD4+ cell turnover.

Authors:  J Sprent; D Tough
Journal:  Nature       Date:  1995-05-18       Impact factor: 49.962

Review 4.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Pathologic features of acquired immunodeficiency-like syndrome in cats experimentally infected with feline immunodeficiency virus.

Authors:  S Matsumura; T Ishida; T Washizu; I Tomoda; S Nagata; J Chiba; T Kurata
Journal:  J Vet Med Sci       Date:  1993-06       Impact factor: 1.267

6.  Molecular cloning of feline immunodeficiency virus.

Authors:  R A Olmsted; A K Barnes; J K Yamamoto; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

8.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

9.  Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR.

Authors:  L J Diehl; C K Mathiason-DuBard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection.

Authors:  T W Vahlenkamp; A De Ronde; J Balzarini; L Naesens; E De Clercq; M J van Eijk; M C Horzinek; H F Egberink
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191
View more
  7 in total

Review 1.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Detection of severe fever with thrombocytopenia syndrome virus and other viruses in cats via unbiased next-generation sequencing.

Authors:  Yasuyuki Momoi; Aya Matsuu
Journal:  J Vet Diagn Invest       Date:  2020-10-21       Impact factor: 1.279

3.  Lentivirus-specific cytotoxic T-lymphocyte responses are rapidly lost in thymectomized cats infected with feline immunodeficiency virus.

Authors:  Kathleen A Hayes; Sadi Köksoy; Andrew J Phipps; Wayne R Buck; Gary J Kociba; Lawrence E Mathes
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.

Authors:  Mauro Pistello; Donatella Matteucci; Francesca Bonci; Patrizia Isola; Paola Mazzetti; Lucia Zaccaro; Antonio Merico; Daniela Del Mauro; Norman Flynn; Mauro Bendinelli
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).

Authors:  Paweł M Bęczkowski; Annette Litster; Tsang Long Lin; Dominic J Mellor; Brian J Willett; Margaret J Hosie
Journal:  Vet Microbiol       Date:  2015-01-03       Impact factor: 3.293

Review 6.  Feline immunodeficiency virus latency.

Authors:  Samantha J McDonnel; Ellen E Sparger; Brian G Murphy
Journal:  Retrovirology       Date:  2013-07-06       Impact factor: 4.602

7.  Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines.

Authors:  Kenji Baba; Fuminori Mizukoshi; Yuko Goto-Koshino; Asuka Setoguchi-Mukai; Yasuhito Fujino; Koichi Ohno; Hajime Tsujimoto
Journal:  Vet Microbiol       Date:  2006-11-27       Impact factor: 3.293
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.